---
title: Intensive Executive Function Training
nct_id: NCT02656758
overall_status: UNKNOWN
phase: NA
sponsor: ZIli Fan
study_type: INTERVENTIONAL
primary_condition: Attention Deficit Hyperactivity Disorder
countries: China
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02656758.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02656758"
ct_last_update_post_date: 2016-10-11
last_seen_at: "2026-05-12T06:44:09.885Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Intensive Executive Function Training

**Official Title:** A Randomized Controlled Study on the Effect of Intensive Functional Training on Children With Attention Deficit Hyperactivity Disorder

**NCT ID:** [NCT02656758](https://clinicaltrials.gov/study/NCT02656758)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 80
- **Lead Sponsor:** ZIli Fan
- **Conditions:** Attention Deficit Hyperactivity Disorder
- **Start Date:** 2016-01
- **Completion Date:** 2018-12
- **CT.gov Last Update:** 2016-10-11

## Brief Summary

The investigators intent to recruit 80 attention deficit hyperactivity disorder families. The attention deficit hyperactivity disorder families had received executive function training one year before.They will be randomized to intervention group and control group using a block randomization design. The intervention group will participate in intensive executive function training immediately,while the control group will receive executive training after 3 months.

## Eligibility

- **Minimum age:** 6 Years
- **Maximum age:** 12 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* clinical diagnosis of child attention deficit hyperactivity disorder
* full-scale intelligence quotient (FSIQ) ≥70
* stable on medication for attention deficit hyperactivity disorder children at least 3 months
* participation in the early implementation of functional training one year before

Exclusion Criteria:

* individuals with major neurological disorders
* a diagnosis of schizophrenia, epilepsy, mental retardation or other brain disorders
```

## Arms

- **Executive function training** (EXPERIMENTAL) — the experimental group will receive 12 sessions of intensive Executive function training weekly immediately
- **the waitlist group** (OTHER) — the waitlist group will wait 12 weeks before receiving intensive executive function training for comparison.

## Interventions

- **intensive Executive function training** (BEHAVIORAL) — Children diagnosis of attention deficit hyperactivity disorder are randomized to the experimental condition(Executive Function training) or waiting group experimental:participants will receive 12 sessions of intensive executive function training weekly no intervention :waiting participants will not be treated with intensive executive function training and keep waiting for 12 weeks for comparison

## Primary Outcomes

- **Change in attention deficit hyperactivity disorder-rating scale** _(time frame: baseline, after the training (12 weeks))_

## Secondary Outcomes

- **Change in behavior rating scale of executive function** _(time frame: baseline, after the training (12 weeks))_
- **Cambridge Neuropsychological Test Automatic Battery** _(time frame: baseline, after the training (12 weeks))_
- **Behavior Rating Inventory of Executive Function** _(time frame: baseline, after the training (12week))_

## Locations (1)

- Peking University Sixth Hospital/Institute of Mental Health, Beijing, Beijing Municipality, China

## Recent Field Changes (last 30 days)

- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.peking university sixth hospital/institute of mental health|beijing|beijing municipality|china` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02656758.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02656758*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*